The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-01
- Target Recruit Count
- 19
- Registration Number
- NCT06621082
Clinical Study on the Treatment of Type I Neurofibromatosis With Smeitinib Hydrosulfate Capsule
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-01
- Target Recruit Count
- 33
- Registration Number
- NCT06620354
mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria
Phase 2
Recruiting
- Conditions
- Hepatocellular Carcinoma Non-resectable
- Interventions
- Drug: mFOLFOX7 combined with Camrelizumab and apatinib
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-09-23
- Target Recruit Count
- 29
- Registration Number
- NCT06607107
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Clinical Outcomes of Thoracodorsal Artery Flap in Oral and Maxillofacial Reconstruction
Not yet recruiting
- Conditions
- Oral Squamous Cell Carcinoma (OSCC)
- Interventions
- Procedure: Anterolateral thigh flap reconstruction surgeryProcedure: Forearm flap reconstruction surgeryProcedure: Forearm flaps reconstruction surgeryProcedure: Fibula flap reconstruction surgeryProcedure: Thoracodorsal artery perforator flap reconstruction surgery
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Target Recruit Count
- 217
- Registration Number
- NCT06599801
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen Univerity, Guangzhou, Guangdong, China
Evaluation of the Safety and Effectiveness of Pringle Method Combined With IVC Flow Limiting and Blocking Method in Laparoscopic Hepatectomy Based on Non-restrictive Fluid Therapy Strategy
Not Applicable
Recruiting
- Conditions
- Liver Tumor
- Interventions
- Procedure: In laparoscopic hepatectomy, the subhepatic inferior vena cava was restricted and the patient was given non-restricted intraoperative fluid intake
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-10-22
- Target Recruit Count
- 220
- Registration Number
- NCT06594289
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China/Guangdong, China
Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC
Recruiting
- Conditions
- Papillary Thyroid Carcinoma
- Interventions
- Procedure: single-incision, gasless endoscopic total thyroidectomy with central compartment neck dissectionProcedure: conventional open surgery
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-10-01
- Target Recruit Count
- 120
- Registration Number
- NCT06592755
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma
Not Applicable
Recruiting
- Conditions
- Hepatocellular CarcinomaAdjuvant Therapy
- Interventions
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2024-09-03
- Target Recruit Count
- 204
- Registration Number
- NCT06581315
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Radiomics for Preoperative Jaw Cyst Differentiation: A Multicenter ML Study
Not yet recruiting
- Conditions
- Jawbone Cysitc Lesion
- Interventions
- Diagnostic Test: different types of computed tomography (CT) scans
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2024-08-30
- Target Recruit Count
- 300
- Registration Number
- NCT06579768
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital,Sun Yat-sen University, Guangzhou, Guangdong, China
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma
Recruiting
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- Drug: Carboplatin（ neoadjuvant）Drug: Anti-PD-1 DrugsProcedure: Surgical resection
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-08-28
- Target Recruit Count
- 306
- Registration Number
- NCT06576180
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guanzhou, Guangdong, China
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
Recruiting
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- Procedure: Surgical resectionDrug: Carboplatin（ neoadjuvant）Drug: Anti-PD-1 Drugs
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-08-28
- Target Recruit Count
- 302
- Registration Number
- NCT06575322
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guanzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath